Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-25-043520
Filing Date
2025-05-01
Accepted
2025-05-01 16:13:21
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 10538
2 EXHIBIT I tm2513821d1_ex-1.htm EX-99.1 5839
  Complete submission text file 0001104659-25-043520.txt   18494
Mailing Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103
Business Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103 646-813-4701
ABEONA THERAPEUTICS INC. (Subject) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-33655 | Film No.: 25903253
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O MILLENNIUM MANAGEMENT LLC 399 PARK AVENUE NEW YORK NY 10022
Business Address C/O MILLENNIUM MANAGEMENT LLC 399 PARK AVENUE NEW YORK NY 10022 (212) 841-4100
INTEGRATED CORE STRATEGIES (US) LLC (Filed by) CIK: 0001319244 (see all company filings)

EIN.: 980330397 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A